Total Funding
79
56
Total FundingGrant raised
Growth Score 79 in past quarter
-15 pts
Heat Score 56 in past quarter
-28 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
56420
Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
- Summer Gibbs: CSO & Co-Founder
- Lei Wang: CTO & Co-Founder
About the Company
Trace Biosciences is working to make safe, precise surgery a reality by creating imaging agents that specifically highlight nerves for surgery. Our technology provides real-time visualization of buried, previously invisible nerves using near-infrared fluorescence that is compatible with clinical imaging systems and has application to every surgical
specialty, so surgeons and surgical robots can cut by color, not by guesswork. With $9.3M raised ($8.1M in non-dilutive capital) and IND-enabling studies complete, we are ready to enter Phase I clinical trials in the coming months and are raising funding to complete Phase II trials, scale for broader clinical impact and commercial partnerships, and bring this transformative platform to every OR.